These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9017418)

  • 41. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion.
    Devine SM; Bartholomew AM; Mahmud N; Nelson M; Patil S; Hardy W; Sturgeon C; Hewett T; Chung T; Stock W; Sher D; Weissman S; Ferrer K; Mosca J; Deans R; Moseley A; Hoffman R
    Exp Hematol; 2001 Feb; 29(2):244-55. PubMed ID: 11166464
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transplantation of gene-modified human bone marrow stromal cells into mouse-human bone chimeras.
    Brouard N; Chapel A; Thierry D; Charbord P; Péault B
    J Hematother Stem Cell Res; 2000 Apr; 9(2):175-81. PubMed ID: 10813530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [In vitro expression of hemophilia B gene mediated by lentivirus].
    Yan DM; Xu KL; Du B; Zeng LY; Lu QX; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):583-6. PubMed ID: 19175982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study of the expression of functional human coagulation factor IX in keratinocytes using a nonviral vector regulated by K14 promoter.
    Hosseini SJ; Zomorodipour A; Jalal R; Sabouni F; Ataei F
    Appl Biochem Biotechnol; 2010 Nov; 162(6):1599-611. PubMed ID: 20397061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice.
    Chuah MK; Van Damme A; Zwinnen H; Goovaerts I; Vanslembrouck V; Collen D; VandenDriessche T
    Hum Gene Ther; 2000 Mar; 11(5):729-38. PubMed ID: 10757352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors.
    Miao CH; Ye X; Thompson AR
    Hum Gene Ther; 2003 Sep; 14(14):1297-305. PubMed ID: 14503965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human bone marrow mesenchymal stem cells expressing SDF-1 promote hematopoietic stem cell function of human mobilised peripheral blood CD34+ cells in vivo and in vitro.
    Liang X; Su YP; Kong PY; Zeng DF; Chen XH; Peng XG; Zou ZM; Xu H
    Int J Radiat Biol; 2010 Mar; 86(3):230-7. PubMed ID: 20201651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I.
    Skottner A; Clark RG; Fryklund L; Robinson IC
    Endocrinology; 1989 May; 124(5):2519-26. PubMed ID: 2707163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene therapy for hemophilia B with liver-specific element mediated by Rep-RBE site-specific integration system.
    Xu Z; Ye J; Zhang A; Xie L; Shen Q; Xue J; Chen J
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):153-9. PubMed ID: 25295466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
    Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
    Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucocorticoid-inducible retrovector for regulated transgene expression in genetically engineered bone marrow stromal cells.
    Jaalouk DE; Eliopoulos N; Couture C; Mader S; Galipeau J
    Hum Gene Ther; 2000 Sep; 11(13):1837-49. PubMed ID: 10986557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Engraftment of genetically modified human amniotic fluid-derived progenitor cells to produce coagulation factor IX after in utero transplantation in mice.
    Yang CM; Gong XL; Qiu J; Tang HX; Gong ZJ; Huang SZ; Zeng F
    Cell Biol Int; 2013 May; 37(5):420-9. PubMed ID: 23504762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ex vivo fibroblast transduction in rabbits results in long-term (>600 days) factor IX expression in a small percentage of animals.
    Chen L; Nelson DM; Zheng Z; Morgan RA
    Hum Gene Ther; 1998 Nov; 9(16):2341-51. PubMed ID: 9829533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistent expression of canine factor IX in hemophilia B canines.
    Chao H; Samulski R; Bellinger D; Monahan P; Nichols T; Walsh C
    Gene Ther; 1999 Oct; 6(10):1695-704. PubMed ID: 10516718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor.
    Gattei V; Aldinucci D; Quinn JM; Degan M; Cozzi M; Perin V; Iuliis AD; Juzbasic S; Improta S; Athanasou NA; Ashman LK; Pinto A
    Cell Growth Differ; 1996 Jun; 7(6):753-63. PubMed ID: 8780889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: feasibility of repeat application to obtain therapeutic levels.
    Wang JM; Zheng H; Blaivas M; Kurachi K
    Blood; 1997 Aug; 90(3):1075-82. PubMed ID: 9242538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
    Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
    Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation.
    Fouillard L; Matthews KE; Guinn BA; Branch DR; Keating A
    Hematology; 1998; 3(5):347-54. PubMed ID: 27414078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone formation following transplantation of genetically modified primary bone marrow stromal cells.
    Sugiyama O; Orimo H; Suzuki S; Yamashita K; Ito H; Shimada T
    J Orthop Res; 2003 Jul; 21(4):630-7. PubMed ID: 12798062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.